I have been for 18 months in the clinical trial for fixed duration of the phase 2 study of the combination of Ibrutinib plus Venetoclax for treatment naive patients.
I became MRD negative after 8 months on the drugs and just got the results of my 3rd bone marrow biopsy: I am still MRD negative!!!
My bone marrow was 85% infiltrated at the onset of the trail.
Thanks to Dr Tom Kipps, Dr Michael Choi and the oncology team at UCSD Moore Cancer Center.